STOCKHOLDERS’ DEFICIT |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ DEFICIT | NOTE 6 – STOCKHOLDERS’ DEFICIT
Series A Preferred Stock
On March 16, 2020, the Company filed a Certificate of Designations (the “Certificate”) with the Secretary of State of Wyoming to amend its Articles of Incorporation to designate the Series A Preferred Stock as a series of preferred stock of the Company. shares of Series A Preferred Stock are authorized in the Certificate. The Series A Preferred Stock has voting rights equivalent to three times the total voting power of the total common stock outstanding at any time. The Series A Preferred Stock has no transfer rights, no conversion rights, no dividends, and no liquidation preference. At December 31, 2025 and 2024, all authorized Series A Preferred Stock are issued and outstanding and held in an escrow account. However, until the shares are released from escrow Mr. Owens controls the votes provided by the Series A Preferred Stock (see Note 1).
Common Stock
At December 31, 2025 and 2024, the Company had and issued and and outstanding shares of common stock, respectively.
On August 27, 2024, the Company amended its articles of incorporation with the State of Wyoming and increased its authorized shares of common stock from to shares.
During the year ended December 31, 2025, several convertible promissory notes totaling $105,000 were converted into of the Company’s common shares (see Note 4).
During the year ended December 31, 2025, convertible promissory notes totaling $3,000 were converted into of the Company’s common shares. To date, these shares have not been issued and therefore, are now in default. The Company is currently in the process of issuing these shares. Until such time as the shares are issued, the Company has presented these shares as common stock to be issued on under other current liabilities in the accompanying balance sheets (see Note 4).
On March 6, 2025, the Company cancelled shares of the Company’s common stock in conjunction with the Asset Purchase Agreement and have been presented as common stock to be issued on the accompanying balance sheets (see Note 3).
During the year ended December 31, 2024, the Company issued shares of common stock to settle liabilities owed to a related party (see Note 3).
During the year ended December 31, 2024, the Company issued shares of common stock to related parties in exchange for intellectual property (see Note 3).
As of December 31, 2025, the Company has not issued a total of common shares due to a third parties. These shares are reflected the weighted-average shares outstanding and are included in the Company’s outstanding shares balance of .
|